6505--Dimethyl Fumarate Capsules

The solicitation requires offerors to submit a fully approved subcontracting plan (individual, company‑wide, or division‑wide) that meets FAR 52.219‑9 and VAAR 852.219‑70, including justification for any goals set below the VA‑suggested or prior‑year achieved levels, a detailed method for identifying potential sources, and a clear statement on whether indirect costs are included in the dollar and percentage goals. Offerors must provide projected subcontract spend for the base period and each option year, state separate dollar and percentage goals for each period, and incorporate a 0.50 % cost‑recovery fee. All covered drug products/NDCs must be listed on the offeror’s FSS contract or interim agreement with a permanent FCP by the offer deadline; non‑compliant offers will be rejected. In addition, contractors must submit quarterly sales reports in U.S. dollars, report cost‑recovery fees, and demonstrate specific internal and external good‑faith efforts to provide equitable subcontracting opportunities to small, veteran‑owned, HUBZone, disadvantaged, and women‑owned businesses. Proposals are to be delivered in Microsoft Word or PDF via email (fax not accepted), include a signed SF‑1449, and may be submitted as multiple offers if the solicitation is awarded by line item. The award is set aside for the listed small‑business categories, and all required FAR provisions (e.g., 52.209‑7, 52.219‑1, 52.204‑24, 52.225‑6) must be completed.

Notice ID

22a51f92b8d040dcab0e65120d2330d0

Solicitation Number

36E79726R0003

NAICS Code

325412

Classification Code

6505